Novartis: towards a reduction of 130 positions in Basel
Article excerpt
Highlighted: the sentence this signal was extracted from
The laboratories responsible for providing support to biological cell banks, analytical testing, and technical development activities are to be moved by the end of 2028 from the Petit-Bâle district to the Novartis campus. The latter plans to transform its Rhine campus into a center for biological treatments, the group specified in a press release. This new restructuring of Novartis' activities in Switzerland comes nine months after the announcement of the last wave of job cuts, Unia notes in a statement. The union emphasizes that the multinational has thus eliminated nearly 3000 jobs in Switzerland since 2018 and is concerned about a questioning of production in the country by the group's management. The employee defense organization also calls for political awareness, considering that a company benefiting from advantageous tax conditions and the quality of Swiss infrastructure should in return be required to invest in research, development, and production in Switzerland. (sda/awp/ats)